Patents by Inventor Jilin Sun

Jilin Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTERNAL REACTOR VESSEL COOLING SYSTEM FOR FLOATING NUCLEAR POWER PLANTS
    Publication number: 20220392653
    Abstract: An ERVC for floating nuclear power plants includes a containment, a reactor vessel, a liquid gallium collection tank, a heat pipe, a cooling cabin and a gallium storage tank. The containment is arranged in a sea environment, and the containment is provided with a containing cavity; the reactor vessel and the liquid gallium collection tank are arranged up and down and located in the containing cavity. An end of the heat pipe is inserted into the liquid gallium collection tank, and another end thereof is arranged outside the liquid gallium collection tank; the gallium storage tank is located in the containing cavity; the gallium storage tank is connected to the liquid gallium collection tank through a liquid gallium release valve; and the cooling cabin is located under the containment and under a sea level of the sea environment.
    Type: Application
    Filed: May 17, 2022
    Publication date: December 8, 2022
    Inventors: GENGLEI XIA, MINJUN PENG, QIANG ZHAO, CHENYANG WANG, YUANDONG ZHANG, JILIN SUN, BOWEN ZHANG, XUE DU
  • Methods of selecting epidermal growth factor receptor (EGFr) binding agents
    Patent number: 9097729
    Abstract: The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr.
    Type: Grant
    Filed: July 26, 2011
    Date of Patent: August 4, 2015
    Assignee: AMGEN INC.
    Inventors: Daniel J. Freeman, Jilin Sun, Kenneth H. Jung, Gary S. Elliott, Robert Radinsky
  • METHODS OF SELECTING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) BINDING AGENTS
    Publication number: 20150051091
    Abstract: The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr.
    Type: Application
    Filed: July 26, 2011
    Publication date: February 19, 2015
    Inventors: Daniel J. Freeman, Jilin Sun, Kenneth H. Jung, Gary S. Elliott, Robert Radinsky
  • METHODS FOR TREATING CONDITIONS ASSOCIATED WITH C-FMS
    Publication number: 20120230987
    Abstract: Antigen binding proteins that bind to human c-fms protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of c-fms to CSF-1, reduce monocyte migration into tumors, and reduce the accumulation of tumor-associated macrophages.
    Type: Application
    Filed: May 8, 2012
    Publication date: September 13, 2012
    Applicant: AMGEN INC.
    Inventors: Kenneth Allan BRASEL, James F. SMOTHERS, Douglas Pat CERRETTI, Christopher MEHLIN, Jilin SUN, Stephen FOSTER
  • Methods of selecting epidermal growth factor receptor (EGFR) binding agents
    Patent number: 7985559
    Abstract: The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: July 26, 2011
    Assignee: AMGEN Inc.
    Inventors: Daniel J. Freeman, Jilin Sun, Kenneth H. Jung, Gary S. Elliott, Robert Radinsky
  • HUMAN C-FMS ANTIGEN BINDING PROTEINS
    Publication number: 20090155164
    Abstract: Antigen binding proteins that bind to human c-fms protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of c-fms to CSF-1, reduce monocyte migration into tumors, and reduce the accumulation of tumor-associated macrophages.
    Type: Application
    Filed: August 20, 2008
    Publication date: June 18, 2009
    Applicant: Amgen, Inc.
    Inventors: Kenneth Allan Brasel, James F. Smothers, Douglas Pat Cerretti, Christopher Mehlin, Jilin Sun, Stephen Foster
  • Methods of selecting epidermal growth factor receptor (EGFR) binding agents
    Publication number: 20090123937
    Abstract: The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr.
    Type: Application
    Filed: October 17, 2008
    Publication date: May 14, 2009
    Inventors: Daniel J. Freeman, Jilin Sun, Kenneth H. Jung, Gary E. Elliott, Robert Radinsky